Litigation Details for MONOSOL RX, LLC v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D. Del. 2017)
✉ Email this page to a colleague
MONOSOL RX, LLC v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D. Del. 2017)
| Docket | ⤷ Subscribe | Date Filed | 2017-09-14 |
| Court | District Court, D. Delaware | Date Terminated | 2018-10-30 |
| Cause | 28:1338 Patent Infringement | Assigned To | Mitchell S. Goldberg |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 8,765,167 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in MONOSOL RX, LLC v. BIODELIVERY SCIENCES INTERNATIONAL, INC.
The small molecule drugs covered by the patent cited in this case are ⤷ Subscribe , ⤷ Subscribe , and ⤷ Subscribe .
Details for MONOSOL RX, LLC v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-01-12 | 1 | of United States Patent No. 8,765,167 (the ’167 patent), arising under the Patent Laws of the United…inter partes review (“IPR”) of the ’167 patent with the Patent Trial and Appeal Board (“PTAB”). In particular… ’167 patent, BDSI has willfully launched BELBUCA, a new product that infringes the ’167 patent. In this…over 150 patents and several FDA approvals. 15. On July 1, 2014, the ’167 patent, entitled…Laura Moss. That patent was assigned to MonoSol. A true and correct copy of the ’167 patent is attached | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
